Form 4: Amgen Director Brian Druker Increases Stake with 809 Share Acquisition Through RSU Vesting

Amgen Inc. Director Brian Druker reported the acquisition of 809 shares of common stock on May 23, 2025, primarily through the vesting of Restricted Stock Units (RSUs) and Dividend Equivalents, increasing his total beneficial ownership to 7,569 shares.

Summary

• Brian Druker, a Director at Amgen Inc. (AMGN), acquired 809 shares of common stock on May 23, 2025.
• The acquisition was primarily due to the immediate vesting of Restricted Stock Units (RSUs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended.
• The transaction price for these shares was $0, indicating a grant or vesting event rather than a cash purchase.
• Following this transaction, Mr. Druker beneficially owns a total of 7,569 shares of Amgen common stock.
• The acquired shares include 417 Dividend Equivalents (DEs) credited on vested but deferred RSUs, which are paid out in shares of the Company's common stock on a one-to-one basis.

Sentiment

Score: 7

Explanation: The transaction reflects an increase in director ownership, which is generally viewed positively as it aligns management interests with shareholders. However, it's a routine compensation event rather than a strategic move, thus not significantly impacting overall sentiment.

Positives

• Director Brian Druker increased his beneficial ownership in Amgen Inc. by 809 shares, signaling continued alignment with shareholder interests.
• The acquisition of shares through RSU vesting and Dividend Equivalents demonstrates the company's commitment to its director incentive program, which is designed to align director compensation with company performance.

Future Outlook

This Form 4 filing reports a past transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine insider transaction report (Form 4) detailing a director's equity compensation. It does not provide information on broader industry trends or competitive landscape, as its scope is limited to individual ownership changes.

Corporate Governance

Related Party Transactions

• Acquisition of 809 shares of common stock by Director Brian Druker from Amgen Inc. through the vesting of Restricted Stock Units (RSUs) and Dividend Equivalents (DEs) as part of the company's established director incentive program.

Stakeholder Impact

• Shareholders: Increased alignment of Director Brian Druker's interests with shareholders due to his increased equity ownership in the company.
• Employees: The transaction is part of a broader equity incentive plan, which can positively influence employee morale and retention if similar programs are available to them.

Key Dates

Keywords

Amgen Inc., AMGN, Form 4, Insider Transaction, Restricted Stock Units, RSU, Dividend Equivalents, Director Compensation, Equity Incentive Plan, Stock Ownership